Bulgun Margaeva

Bulgun Margaeva has a strong background in the pharmaceutical industry. Bulgun began their career in 2007 at AstraZeneca as a Sr. Medical representative and worked there until 2012. Bulgun then joined Amgen as a Medical Advisor in Nephrology from 2012 to 2015. In 2015, Bulgun joined Novartis as a Sr. Medical Advisor and worked there for four years until 2019. Bulgun then moved on to Roche as a Country Medical Director, where they worked for three years until 2022. Currently, Bulgun is the Head of Feasibility and Therapeutic Strategy at Cromos Pharma.

Bulgun Margaeva attended the First Moscow State Medical University named after I.M. Sechenov from 2002 to 2007. No specific degree or field of study information is available for this period.